Program
Diclofenac Sodium Gel
Also written as “Diclofenac sodium gel 1%”, “Voltaren Gel” and “Diclofenac sodium gel”.
Its studies are mostly in Keratosis, Actinic · Osteoarthritis, Knee · Osteoarthritis · Pain · Myalgia, led by 8 companies.
Drug pageDiclofenac Sodium Gel: every studyMany companies study it; this page follows only the 11 they lead. All 20 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novartisits history only | 30 open or running | phase 3since Sep 13, 2005 | Sep 13, 2005 | none ahead |
| Amzellits history only | 20 open or running | phase 1since Jul 7, 2023 | Jul 7, 2023 | none ahead |
| Akornits history only | 10 open or running | phase 3since Sep 22, 2016 | Sep 22, 2016 | none ahead |
| Encube Ethicals Pvt.its history only | 10 open or running | phase 3since Jan 30, 2019 | Jan 30, 2019 | none ahead |
| Glenmark Pharmaceuticals Ltd. Indiaits history only | 10 open or running | phase 3since Nov 3, 2015 | Nov 3, 2015 | none ahead |
| HALEONits history only | 10 open or running | phase 4since Apr 18, 2024 | Apr 18, 2024 | none ahead |
| Sun Pharmaceutical Industriesits history only | 10 open or running | phase 1since Dec 3, 2012 | Dec 3, 2012 | none ahead |
| Viatrisits history only | 10 open or running | phase 3since May 30, 2017 | May 30, 2017 | none ahead |
Also a collaborator on its studies: Novum Pharmaceutical Research Services.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 13, 2005First study: phase 3 study in OsteoarthritisNew to NovartisNovartis · NCT00171652 · 360 enrolled · France, Germany
- Jan 24, 2007Phase 3 study in Osteoarthritis, KneeNovartis · NCT00426621 · 420 enrolled · United States
- Dec 3, 2012Sun Pharmaceutical Industries’ first study: phase 1 study in Keratosis, ActinicNew to Sun Pharmaceutical IndustriesSun Pharmaceutical Industries · NCT01742663 · 435 enrolled
- Oct 20, 2014Phase 3 study in MyalgiaNovartis · NCT02271854 · 102 enrolled · United States
- Nov 3, 2015Glenmark Pharmaceuticals Ltd. India’s first study: phase 3 study in OsteoarthritisNew to Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals Ltd. India · NCT02596451 · 1,164 enrolled · United States
- Sep 22, 2016Akorn’s first study: phase 3 study in Osteoarthritis, KneeNew to AkornAkorn · NCT02913521 · 934 enrolled · Estonia, Latvia, Lithuania and more
- May 30, 2017Viatris’s first study: phase 3 study in Osteoarthritis, KneeNew to ViatrisViatris · NCT03172780 · 1,220 enrolled · India
- Jan 30, 2019Encube Ethicals Pvt.’s first study: phase 3 study in Keratosis, ActinicNew to Encube Ethicals Pvt.Encube Ethicals Pvt. · NCT03826550 · 655 enrolled · United States
- Jul 7, 2023Amzell’s first study: phase 1 study in HealthyNew to AmzellAmzell · NCT05968482 · 74 enrolled · United States
- Apr 18, 2024HALEON’s first study: phase 4 study in PainNew to HALEONHALEON · NCT06379893 · 196 enrolled · United States, Poland
- Dec 6, 2024Phase 1 study in Healthy VolunteerAmzell · NCT06729073 · 34 enrolled · Germany
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 11 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06729073Healthy Volunteer · Germany | 1 | Completed | Amzell | Jun 10, 2025 | 34 |
| NCT06379893Pain · United States, Poland | 4 | Completed | HALEON | Oct 29, 2024 | 196 |
| NCT05968482Healthy · United States | 1 | Completed | Amzell | Dec 27, 2023 | 74 |
| NCT03826550Keratosis, Actinic · United States | 3 | Completed | Encube Ethicals Pvt. | Jun 30, 2018 | 655 |
| NCT03172780Osteoarthritis, Knee · India | 3 | Completed | Viatris | Dec 5, 2017 | 1,220 |
| NCT02913521Osteoarthritis, Knee · Estonia, Latvia, Lithuania and more | 3 | Completed | Akorn | Apr 2016 | 934 |
| NCT02596451Osteoarthritis · United States | 3 | Completed | Glenmark Pharmaceuticals Ltd. India | Mar 2016 | 1,164 |
| NCT02271854Myalgia · United States | 3 | Completed | Novartis | Dec 2014 | 102 |
| NCT01742663Keratosis, Actinic | 1 | Completed | Sun Pharmaceutical Industries | Jul 2013 | 435 |
| NCT00426621Osteoarthritis, Knee · United States | 3 | Completed | Novartis | 420 | |
| NCT00171652Osteoarthritis · France, Germany | 3 | Completed | Novartis | 360 |
How it is read
Names in the registry
- “Diclofenac Sodium Gel”, 3 entries
- “Diclofenac sodium gel 1%”, 3 entries
- “Voltaren Gel”, 1 entry
- “Diclofenac sodium gel”, 1 entry
- “Diclofenac sodium gel 3%”, 1 entry
Conditions, from the studies’ own filings
- Keratosis, Actinic, 3 studies
- Osteoarthritis, Knee, 3 studies
- Osteoarthritis, 2 studies
- Pain, 1 study
- Myalgia, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.